| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 16, 2010Further Clinical Study Required for Application to U.S. Food and Drug Administration
MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
-
Jun 25, 2010Semi-Closed Loop System Designed to Reduce Severity and Duration of Hypoglycemia
MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. (NYSE:MDT) today announced that the first patient has been...
-
Jun 2, 2010
MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
-
Mar 18, 2010
MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
-
Mar 17, 2010Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...